Organogenesis Holding (ORGO) Reports In-Line Q4 EPS

Organogenesis Holding (NASDAQ: ORGO) reported Q4 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $115.5 million versus the consensus estimate of $122.05 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Vertex to acquire Crinetics Pharmaceuticals for $10 billion
• ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies